GEN Exclusives

More »

GEN News Highlights

More »
Jan 3, 2008

Third Mechanism for Activating Ion Channels Identified

  • Scientists at the University of Leeds have discovered a previously unknown mechanism that opens ion channels. Until now, according to the researchers, two main groups of activating mechanisms have been acknowledged: changes in cell voltage and binding of chemical factors.

    David Beech, Ph.D., and colleagues from the University’s faculty of biological sciences found that thioredoxin donates electrons to an ion channel thus activating it.

    “Thioredoxin is naturally present in cells and is secreted to help the body counter stressful chemical reactions that occur in inflammation, which can damage cells,” he explains. “We already knew that inflammatory diseases cause the production of high levels of thioredoxin. In fact with rheumatoid arthritis, it’s striking how much is present in affected joints. But, we didn’t know until now that thioredoxin can also activate ion channels, conferring additional protective potential and offering opportunities for mimicking the effect with drugs.”

    The research was funded by the Wellcome Trust. Findings are published in the January 3 issue of Nature.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »